Key facts
| Price (PPV) | 29.50 MAD |
|---|---|
| Dispensing status | Unscheduled — no prescription needed |
| Composition (DCI) | econazole |
| Class | Antifungals for dermatological use |
| ATC code | D01AC03 |
| Manufacturer | PHARMA5 |
| Presentation | Tube de 30 g |
| Nature | Médicament |
| Hospital price | 18.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Candidoses Les candidoses cutanées rencontrées en clinique humaine sont habituellement dues à Candida albicans. Cependant, la mise en évidence d'un Candida sur la peau ne peut constituer en soi une indication. · Traitement des mycoses des plis non macérées : intertrigo génital, sous-mammaire, interdigital. · Traitement des mycoses des ongles : onyxis, périonyxis. Un traitement systémique antifongique associé est nécessaire. Le traitement antifongique d’un foyer digestif et/ou vaginal éventuel s’impose dans les candidoses des plis inguinaux et inter-fessiers pour éviter les récidives. Dermatophyties · Traitement : o Dermatophyties de la peau glabre. o Intertrigos génitaux et cruraux non macérées. · Traitement des teignes. Un traitement systémique antifongique associé est nécessaire.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Fungilyse 1 % (LAPROPHAN) contains the same active substance as Pevagine 1 % (Econazole) at the same strength, but in a different pack: Tube de 25 g at 15.20 MAD, i.e. 0.61 MAD per g against 0.98 MAD for Pevagine 1 %. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Fungilyse 1 % | LAPROPHAN | Tube de 25 g | 15.20 MAD | 0.61 / g |
| Fungilyse 1 % | LAPROPHAN | Tube de 50 g | 28.50 MAD | 0.57 / g |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Pevagine 1 %
Pevagine 1 % belongs to the antifungals for dermatological use therapeutic class. In Morocco, this drug is marketed by PHARMA5 and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Pevagine 1 %, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Pevagine 1 %
Answers to common questions from Moroccan patients about this drug.